Biohaven's Nurtec® ODT Signs as Primary Partner with Rick Ware Racing for 2021 NTT INDYCAR Series Program
Retrieved on:
Friday, May 14, 2021
b'MOORESVILLE, N.C., May 14, 2021 /PRNewswire/ --Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Nurtec ODT (rimegepant) willbe the primary partner for the Rick Ware Racing No.
Key Points:
- b'MOORESVILLE, N.C., May 14, 2021 /PRNewswire/ --Biohaven Pharmaceuticals (NYSE:BHVN) announced today that Nurtec ODT (rimegepant) willbe the primary partner for the Rick Ware Racing No.
- "Nurtec ODT is one, if not the only, partner in both the NASCAR Cup Series and NTT IndyCar Series, whose primary colors are on board every weekend.
- We have created some great programs for the 2021 season, and I\'m excited to expand the program to cover the IndyCar Series full-time as well.
- "\nVlad Coric, M.D., Chief Executive Officer of Biohaven said, "We are having a great season thus far with the NASCAR Cup Series and look forward to continuing our partnership with the Rick Ware Racing team for the NTT IndyCar Series.